FACTOR XA INHIBITOR
Clinical trials for FACTOR XA INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new FACTOR XA INHIBITOR trials appear
Sign up with your email to follow new studies for FACTOR XA INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a lifesaving stroke treatment be safe for thousands denied it?
Disease control Recruiting nowThis trial is testing if a common emergency clot-busting treatment for stroke is safe and effective for people who take a specific type of blood thinner (Factor Xa inhibitors). Currently, guidelines often prevent these patients from receiving this treatment due to bleeding concer…
Matched conditions: FACTOR XA INHIBITOR
Phase: PHASE3 • Sponsor: Guri Hagberg • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
Drug safety under scrutiny for emergency bleeding treatment
Disease control Recruiting nowThis study aims to monitor the safety of a drug called Ondexxya, which is used in emergencies to reverse the effects of certain blood thinners in patients with life-threatening bleeding. It will enroll 300 patients who received the drug in real-world hospital settings. The main g…
Matched conditions: FACTOR XA INHIBITOR
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC